Meflonidone hydrochloride

盐酸美氟尼酮

Report date: 2023/04/03 20:00:22
NME

Base Information

Drug NameMeflonidone hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCentral South UniversityGuangzhou Nanxin Pharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCentral South UniversityGuangzhou Nanxin Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A